| abstract |
(57) [Summary]nThe present invention provides a method of treating or preventing intestinal disorders caused by elevated TNF levels in the lumen of the intestine of a patient. The method comprises administering to the patient a component that reduces the effect of TNF in the lumen or reduces the production or accumulation of TNF in the lumen. This component can be any of the known anti-TNF components, but anti-TNF antibodies are preferred. It is also preferred that this component be administered directly to the intestine. |